DNLI News and Sentiment Evidence
DNLI news snapshot: Sentiment factor: 81/100; Latest headline: Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million; Source: manilatimes.net.
| Metric | Value |
|---|---|
| Sentiment factor | 81/100 |
| Latest headline | Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million |
| Source | manilatimes.net |
| Published | 2026-06-18T12:16:28.000000Z |
| News items loaded | 8 |
Related Links
Concepts For This Tab
Learn Library
Explore This Stock
Loading news...